Frederico O Gleber-Netto1, Mei Zhao1, Sanchit Trivedi1, Jiping Wang1, Samar Jasser1, Christina McDowell2, Humam Kadara2, Jiexin Zhang3, Jing Wang3, William N William4, J Jack Lee5, Minh Ly Nguyen6, Sara I Pai7, Heather M Walline8, Dong M Shin9, Robert L Ferris10, Thomas E Carey8, Jeffrey N Myers1, Curtis R Pickering1. 1. Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 3. Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 4. Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 5. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. 6. Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia. 7. Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts. 8. Department of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan. 9. Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia. 10. Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND: Human immunodeficiency virus-infected individuals (HIVIIs) have a higher incidence of head and neck squamous cell carcinoma (HNSCC), and clinical and histopathological differences have been observed in their tumors in comparison with those of HNSCC patients without a human immunodeficiency virus (HIV) infection. The reasons for these differences are not clear, and molecular differences between HIV-related HNSCC and non-HIV-related HNSCC may exist. This study compared the mutational patterns of HIV-related HNSCC and non-HIV-related HNSCC. METHODS: The DNA of 20 samples of HIV-related HNSCCs and 32 samples of non-HIV-related HNSCCs was sequenced. DNA libraries covering exons of 18 genes frequently mutated in HNSCC (AJUBA, CASP8, CCND1, CDKN2A, EGFR, FAT1, FBXW7, HLA-A, HRAS, KEAP1, NFE2L2, NOTCH1, NOTCH2, NSD1, PIK3CA, TGFBR2, TP53, and TP63) were prepared and sequenced on an Ion Personal Genome Machine sequencer. DNA sequencing data were analyzed with Ion Reporter software. The human papillomavirus (HPV) status of the tumor samples was assessed with in situ hybridization, the MassARRAY HPV multiplex polymerase chain reaction assay, and p16 immunostaining. Mutation calls were compared among the studied groups. RESULTS: HIV-related HNSCC revealed a distinct pattern of mutations in comparison with non-HIV-related HNSCC. TP53 mutation frequencies were significantly lower in HIV-related HNSCC. Mutations in HIV+ patients tended to be TpC>T nucleotide changes for all mutated genes but especially for TP53. CONCLUSIONS: HNSCC in HIVIIs presents a distinct pattern of genetic mutations, particularly in the TP53 gene. HIV-related HNSCC may have a distinct biology, and an effect of the HIV virus on the pathogenesis of these tumors should not be ruled out. Cancer 2018;124:84-94.
BACKGROUND:Humanimmunodeficiency virus-infected individuals (HIVIIs) have a higher incidence of head and neck squamous cell carcinoma (HNSCC), and clinical and histopathological differences have been observed in their tumors in comparison with those of HNSCC patients without a human immunodeficiency virus (HIV) infection. The reasons for these differences are not clear, and molecular differences between HIV-related HNSCC and non-HIV-related HNSCC may exist. This study compared the mutational patterns of HIV-related HNSCC and non-HIV-related HNSCC. METHODS: The DNA of 20 samples of HIV-related HNSCCs and 32 samples of non-HIV-related HNSCCs was sequenced. DNA libraries covering exons of 18 genes frequently mutated in HNSCC (AJUBA, CASP8, CCND1, CDKN2A, EGFR, FAT1, FBXW7, HLA-A, HRAS, KEAP1, NFE2L2, NOTCH1, NOTCH2, NSD1, PIK3CA, TGFBR2, TP53, and TP63) were prepared and sequenced on an Ion Personal Genome Machine sequencer. DNA sequencing data were analyzed with Ion Reporter software. The human papillomavirus (HPV) status of the tumor samples was assessed with in situ hybridization, the MassARRAY HPV multiplex polymerase chain reaction assay, and p16 immunostaining. Mutation calls were compared among the studied groups. RESULTS:HIV-related HNSCC revealed a distinct pattern of mutations in comparison with non-HIV-related HNSCC. TP53 mutation frequencies were significantly lower in HIV-related HNSCC. Mutations in HIV+ patients tended to be TpC>T nucleotide changes for all mutated genes but especially for TP53. CONCLUSIONS: HNSCC in HIVIIs presents a distinct pattern of genetic mutations, particularly in the TP53 gene. HIV-related HNSCC may have a distinct biology, and an effect of the HIV virus on the pathogenesis of these tumors should not be ruled out. Cancer 2018;124:84-94.
Authors: Michael S McLemore; Missak Haigentz; Richard V Smith; Gerard J Nuovo; Llucia Alos; Antonio Cardesa; Margaret Brandwein-Gensler Journal: Head Neck Pathol Date: 2010-03-24
Authors: Ge Zhou; Jiping Wang; Mei Zhao; Tong-Xin Xie; Noriaki Tanaka; Daisuke Sano; Ameeta A Patel; Alexandra M Ward; Vlad C Sandulache; Samar A Jasser; Heath D Skinner; Alison Lea Fitzgerald; Abdullah A Osman; Yongkun Wei; Xuefeng Xia; Zhou Songyang; Gordon B Mills; Mien-Chie Hung; Carlos Caulin; Jiyong Liang; Jeffrey N Myers Journal: Mol Cell Date: 2014-05-22 Impact factor: 17.970
Authors: Marie Helleberg; Jan Gerstoft; Shoaib Afzal; Gitte Kronborg; Carsten S Larsen; Court Pedersen; Stig E Bojesen; Børge G Nordestgaard; Niels Obel Journal: AIDS Date: 2014-06-19 Impact factor: 4.177
Authors: Gypsyamber Dʼsouza; Thomas E Carey; William N William; Minh Ly Nguyen; Eric C Ko; James Riddell; Sara I Pai; Vishal Gupta; Heather M Walline; J Jack Lee; Gregory T Wolf; Dong M Shin; Jennifer R Grandis; Robert L Ferris Journal: J Acquir Immune Defic Syndr Date: 2014-04-15 Impact factor: 3.731
Authors: Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris Journal: Nature Date: 2013-02-06 Impact factor: 49.962
Authors: Reuben H Kim; Ji Min Yochim; Mo K Kang; Ki-Hyuk Shin; Russell Christensen; No-Hee Park Journal: Int J Oncol Date: 2008-10 Impact factor: 5.650
Authors: Curtis R Pickering; Jiexin Zhang; David M Neskey; Mei Zhao; Samar A Jasser; Jiping Wang; Alexandra Ward; C Jillian Tsai; Marcus V Ortega Alves; Jane H Zhou; Jennifer Drummond; Adel K El-Naggar; Richard Gibbs; John N Weinstein; David A Wheeler; Jing Wang; Mitchell J Frederick; Jeffrey N Myers Journal: Clin Cancer Res Date: 2014-05-29 Impact factor: 12.531
Authors: Jennifer S Moore; Firoz Rahemtulla; Leigh W Kent; Stacy D Hall; Mine R Ikizler; Peter F Wright; Huan H Nguyen; Susan Jackson Journal: Virology Date: 2003-09-01 Impact factor: 3.616
Authors: Jonathan Shuter; Krishna P Reddy; Emily P Hyle; Cassandra A Stanton; Nancy A Rigotti Journal: Lancet HIV Date: 2021-08-27 Impact factor: 16.070
Authors: M K Gandhi; T Hoang; S C Law; S Brosda; K O'Rourke; J W D Tobin; F Vari; V Murigneux; L Fink; J Gunawardana; C Gould; H Oey; K Bednarska; S Delecluse; R U Trappe; L Merida de Long; M B Sabdia; G Bhagat; G Hapgood; E Blyth; L Clancy; J Wight; E Hawkes; L M Rimsza; A Maguire; K Bojarczuk; B Chapuy; C Keane Journal: Blood Date: 2021-03-18 Impact factor: 22.113
Authors: Mario Pérez Sayáns; Cintia Micaela Chamorro Petronacci; Alejandro Ismael Lorenzo Pouso; Elena Padín Iruegas; Andrés Blanco Carrión; José Manuel Suárez Peñaranda; Abel García García Journal: J Clin Med Date: 2019-11-07 Impact factor: 4.241
Authors: Samuel Franklin Weinreb; Krzysztof Piersiala; Shumon Ian Dhar; Alexander T Hillel; Lee Akst; Simon R A Best Journal: Laryngoscope Investig Otolaryngol Date: 2022-01-19
Authors: Valerio Vitelli; Paolo Falvo; Solomon G Nergadze; Marco Santagostino; Lela Khoriauli; Paola Pellanda; Giulia Bertino; Antonio Occhini; Marco Benazzo; Patrizia Morbini; Marco Paulli; Camillo Porta; Elena Giulotto Journal: Int J Mol Sci Date: 2018-01-17 Impact factor: 5.923